Cancer News and Research

Latest Cancer News and Research

Opioid prescription use found to be more common among cancer survivors

A new study found that opioid prescription use is more common in cancer survivors than in individuals without a history of cancer.

7 Aug 2017

Herbal remedy plants show promise to combat cancer

Herbal remedy plants native to Saudi Arabia are shown to have potential as treatments for cancer. Researchers from KAUST have been searching locally for plants that have potential for use to combat cancer.

7 Aug 2017

JAX receives new federal research grant to study mouse models of ALS

A new five-year federal research grant totaling $3,322,009 to The Jackson Laboratory (JAX) will fund studies of a new mouse model for amyotrophic lateral sclerosis (ALS).

4 Aug 2017

New method for evaluating drug safety can detect stress on cells at earlier stages

A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death.

4 Aug 2017

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

Neuroscientists have uncovered the genetic basis for why many long-term survivors of childhood cancer develop meningiomas, the most common adult brain tumor, decades after their treatment with cranial radiation.

4 Aug 2017

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.

4 Aug 2017

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.

4 Aug 2017

Study sheds new light on how anti-cancer agent inhibits tumor growth

Researchers at Sanford Burnham Prebys Medical Discovery Institute have published a study in Nature Communications shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at the Institute, prevents activation of the PI3K pathway, resulting in inhibition of cancer cell growth.

4 Aug 2017

Most common myths about use of e-cigarettes

The Government has recently announced its ‘Tobacco Control Plan’ which aims to slash smoking rates from 15.5% to 12% of the population by 2022.

4 Aug 2017

Cellular aging process can promote idiopathic pulmonary fibrosis

Pulmonary fibrosis can possibly be attributed to a kind of cellular aging process, which is called senescence. This has been shown by researchers from the Helmholtz Zentrum München, partner in the German Center for Lung Research.

4 Aug 2017

Immune ‘hotspots’ could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

4 Aug 2017

Advanced statistical modeling and analytic tools can make health care, medical data more meaningful

Recognizing that administrative health care databases can be a valuable, yet challenging, tool in the nation's ongoing pursuit of personalized medicine, statisticians Liangyuan Hu and Madhu Mazumdar of the Icahn School of Medicine at Mount Sinai have developed advanced statistical modeling and analytic tools that can make health care and medical data more meaningful.

4 Aug 2017

Researchers find higher proportion of aggressive breast cancer subtypes in black women

A higher proportion of aggressive breast cancer subtypes are seen in black women, University of North Carolina Lineberger Comprehensive Cancer Center researchers have found.

4 Aug 2017

UAMS scientists awarded $422,610 NSF grant to study regulation of emotion

A team of University of Arkansas for Medical Sciences research scientists recently received a $422,610 grant from the National Science Foundation to study the mechanisms of control of emotional responses of men and women using functional magnetic resonance imaging (fMRI).

3 Aug 2017

Experimental drug protects mice from obesity-related liver disease

A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease.

3 Aug 2017

Studies show how endoscopic procedures can improve outcomes and care

Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy, features a study reporting that a simpler procedure for collecting biopsy specimens during various procedures can improve patient care, and a study showing how a relatively new procedure, POEM, has been adapted to help an additional set of patients with gastroparesis, a troubling stomach problem.

3 Aug 2017

UVA researchers identify connection between dopamine neurons and brain’s circadian center

Neurons in the brain that produce the pleasure-signaling neurotransmitter dopamine also directly control the brain's circadian center, or "body clock" - the area that regulates eating cycles, metabolism and waking/resting cycles - a key link that possibly affects the body's ability to adapt to jet lag and rotating shift work, a new University of Virginia study has demonstrated.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Cancer News and Research

Latest Cancer News and Research

Opioid prescription use found to be more common among cancer survivors

Herbal remedy plants show promise to combat cancer

JAX receives new federal research grant to study mouse models of ALS

New method for evaluating drug safety can detect stress on cells at earlier stages

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Study sheds new light on how anti-cancer agent inhibits tumor growth

Most common myths about use of e-cigarettes

Cellular aging process can promote idiopathic pulmonary fibrosis

Immune ‘hotspots’ could help predict the risk of breast cancer relapse in patients, study finds

Advanced statistical modeling and analytic tools can make health care, medical data more meaningful

Researchers find higher proportion of aggressive breast cancer subtypes in black women

UAMS scientists awarded $422,610 NSF grant to study regulation of emotion

Experimental drug protects mice from obesity-related liver disease

Studies show how endoscopic procedures can improve outcomes and care

UVA researchers identify connection between dopamine neurons and brain’s circadian center

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Understanding the DNA Damage Response in Innate Immunity eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Newsletters you may be interested in